NASDAQ:OM - Outset Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $59.33
  • Forecasted Upside: 7.92 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$54.98
▲ +1.22 (2.27%)

This chart shows the closing price for OM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Outset Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OM

Analyst Price Target is $59.33
▲ +7.92% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Outset Medical in the last 3 months. The average price target is $59.33, with a high forecast of $70.00 and a low forecast of $54.00. The average price target represents a 7.92% upside from the last price of $54.98.

This chart shows the closing price for OM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 contributing investment analysts is to buy stock in Outset Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/21/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/20/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/18/2021CowenInitiated CoverageOutperform$70.00High
8/9/2021Morgan StanleyLower Price TargetEqual Weight$60.00 ➝ $55.00High
5/6/2021Morgan StanleyBoost Price TargetEqual Weight$58.00 ➝ $60.00High
4/19/2021Wells Fargo & CompanyInitiated CoverageOverweight$63.00Low
3/10/2021Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $58.00Low
12/16/2020OppenheimerInitiated CoverageMarket PerformLow
12/15/2020OppenheimerInitiated CoverageMarket PerformMedium
12/15/2020Morgan StanleyBoost Price TargetEqual Weight$48.00 ➝ $52.00Low
10/12/2020BarclaysInitiated CoverageOverweightHigh
10/12/2020Morgan StanleyInitiated CoverageEqual Weight$48.00Low
10/12/2020Stifel NicolausInitiated CoverageBuy$54.00Low
10/12/2020SVB LeerinkInitiated CoverageMarket Perform$60.00Low
10/12/2020Bank of AmericaInitiated CoverageBuyLow
10/12/2020The Goldman Sachs GroupInitiated CoverageBuy$54.00Low
(Data available from 9/19/2016 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/21/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2021
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/20/2021
  • 3 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
9/19/2021

Current Sentiment

  • 3 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Outset Medical logo
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $54.98
Low: $52.70
High: $55.16

50 Day Range

MA: $44.42
Low: $36.86
High: $54.98

52 Week Range

Now: $54.98
Low: $36.03
High: $66.96

Volume

1,762,668 shs

Average Volume

458,387 shs

Market Capitalization

$2.55 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Outset Medical?

The following sell-side analysts have issued research reports on Outset Medical in the last year: Bank of America Co., Barclays PLC, Cowen Inc, Morgan Stanley, Oppenheimer Holdings Inc., Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for OM.

What is the current price target for Outset Medical?

6 Wall Street analysts have set twelve-month price targets for Outset Medical in the last year. Their average twelve-month price target is $59.33, suggesting a possible upside of 7.9%. Cowen Inc has the highest price target set, predicting OM will reach $70.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $54.00 for Outset Medical in the next year.
View the latest price targets for OM.

What is the current consensus analyst rating for Outset Medical?

Outset Medical currently has 3 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OM will outperform the market and that investors should add to their positions of Outset Medical.
View the latest ratings for OM.

What other companies compete with Outset Medical?

How do I contact Outset Medical's investor relations team?

Outset Medical's physical mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The company's listed phone number is 669-231-8200 and its investor relations email address is [email protected] The official website for Outset Medical is outsetmedical.com.